Fig. 7From: Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatmentOn the left, 68 Ga-PSMA PET image for a patient with a metastatic castration-resistant prostate cancer. On the right, 5 planar images obtained from SPECT reconstructions (RecVis) after the first five injections of 177Lu-PSMA. The PSA levels measured at each treatment are 63.50, 26.60, 4.51, 1.81 and 0.92 ng/mL, respectivelyBack to article page